Skip to content

management of chronic bronchitis with homoeopathic therapy

A MULTICENTRIC OPEN CLINICAL TRAIL TO EVOLVE A EFFICACIOUS HOMOEOPATHIC MEDICINES IN SIMPLE AND MUCOPURULENT CHRONIC BRONCHITIS WITH REGARD TO IMPROVEMENT IN SYMPTOM COMPLEX OF SIMPLE AND MUCOPURULENT CHRONIC BRONCHITIS"

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/09/001994
Enrollment
1050
Registered
2011-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients suffering from simple and mucopurulent chronic bronchitis

Interventions

Intervention1: homoeopathic medicine Stannum metallicum, Arsenicum album, 1. Silicea, Phosphorus, 2. Lycopodium 3. Pulsatilla. Calcarea carb, 4. Sulphur, 5. Hepar sulph, Ipecacuan

Sponsors

central council for research in homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of Chronic Bronchitis as mentioned in (4.1) without any complications, from any sex and between 20 and 50 years of age fulfilling the following requirements: ? Willing to participate in the study and willing to come for the follow-up visits for two years at prescribed intervals, ? Residing within approachable distance from the center, ? Cases who are not, currently, on any other treatment, including homoeopathy, ? With cases who have taken any treatment, at least two-weeks? treatment-free interval should have lapsed before the screening phase.

Exclusion criteria

Exclusion criteria: 1. Subjects currently on any other treatment (Homoeopathy or other systems) 2. Subjects who have discontinued treatment less than two weeks before, 3. Chronic bronchitis, NOS(J42) and obstructive(J44) as per ICD 10 4. Subjects suffering from Emphysema, cor Pulmonale, Bronchial asthma, Bronchiectasis, Active pulmonary tuberculosis (open), Cystic fibrosis, Bronchopulmonary mycosis, Central airflow obstruction, Acute bronchitis, Pneumonia, Pulmonary thrombo-embolism, Left ventricular failure, Pulmonary hypertension, Chronic respiratory failure, Spontaneous pneumothorax, Bronchogenic carcinoma. 5. Persons requiring oxygen therapy and hospitalization; 6. Cough due to some other underlying disease. 7. FEV,: 80% PREDICTED 8. FEV1 / FVC 0.7

Design outcomes

Primary

MeasureTime frame
improvement in symptom score of chronic bronchitis patientsTimepoint: improvement in symptom score of chronic bronchitis patients in 2 years follow up;improvement in symptom score of chronic bronchitis patientsTimepoint: improvement in symptom score of chronic bronchitis patients in 2 years follow up;improvement in symptom score of chronic bronchitis patientsTimepoint: improvement in symptom score of chronic bronchitis patients in 2 years follow up;improvement in symptom score of chronic bronchitis patientsTimepoint: improvement in symptom score of chronic bronchitis patients in 2 years follow up

Secondary

MeasureTime frame
improvement in spirometry readingTimepoint: 2 years;improvement in spirometry reading, FEV180%Timepoint: improvement in spirometry reading, FEV180% in 2 years

Countries

India

Contacts

Public ContactDr. Jaya Gupta

central council for research in homoeopathy

jgupta21@gmail.com9818281733

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026